Session on Managed Entry Agreements

Really interesting session - who knew there were so many clever ways to get early access to new medicines without breaking the bank our our Payers !

And at AIFA the Italian HTA used a pay per performance scheme for our Targeted Therapies :

Then the great Dutch Melanoma Registry - gathering all the Patient data to really be able to make clever decisions on what works for who (less wasteful and painful treatments given un-necessarily) and then clever payer decisions !

Why are we not all doing this in europe - this is quality data collection, best patient care and cheaper for our countries to afford !

Let us avoid this :

We really be EXPECTING our countries to use these tools rather than hold back access - they EXIST  let us share experiences and collaborate !